SCHEMBL29620952

SCHEMBL29620952

O=C(O)c1ccc(C(F)(F)F)c(F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.57
LMNA P02545 2/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
TTR P02766 1/20 0.50
KCNQ3 O43525 1/20 0.48
KCNQ2 O43526 1/20 0.48
KCNE1 P15382 1/20 0.48
KCNQ1 P51787 1/20 0.48
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46
RXRG P48443 1/20 0.46
SRD5A2 P31213 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.42
RORC P51449 1/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42
RARA P10276 1/20 0.42
RARB P10826 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL850429 1.00 KIF11 (0.57) KIF11LMNAMAPK1HTTRAB9A
Hydrochloric Acid SCHEMBL31439018 0.98 KIF11 (0.56) KIF11LMNAMAPK1HTTRAB9A
SCHEMBL418896 0.86 LMNA (0.49) KIF11LMNAMAPK1HTTRAB9A
SCHEMBL16104820 0.85 LMNA (0.51) KIF11LMNAMAPK1HTTRAB9A
SCHEMBL5360083 0.85 LMNA (0.47) KIF11LMNAMAPK1HTTRAB9A
SCHEMBL31438988 0.84 TAS1R3 (0.54) KIF11LMNAMAPK1HTTRAB9A
SCHEMBL78878 0.84 TAS1R3 (0.54) KIF11LMNAMAPK1HTTRAB9A
SCHEMBL827082 0.83 RXRA (0.48) KIF11TTRRXRARXRBRXRG
SCHEMBL31319449 0.83 RXRA (0.48) KIF11TTRRXRARXRBRXRG
SCHEMBL313169 0.82 KIF11 (0.75) KIF11KCNQ3KCNQ2KCNE1KCNQ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116003309-B Hydrazide compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2025-03-04 CN disclosed
CN-114846004-B Antimalarial drugs 德克萨斯大学系统董事会 2024-10-11 CN disclosed
EP-4430047-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2024-09-18 EP disclosed
CN-114450281-B Inhibitor compounds 辛塞拉治疗私人有限公司 2024-08-16 CN disclosed
CN-118475580-A Platelet-derived growth factor receptor (PDGFR) alpha inhibitors and uses thereof 普罗根托斯治疗公司 2024-08-09 CN disclosed
CN-113024467-B PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof 米托布里奇公司 2024-08-06 CN disclosed
CN-112313209-B Herbicidal compounds 先正达农作物保护股份公司 2024-07-26 CN disclosed
CN-113004205-B PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof 米托布里奇公司 2024-07-02 CN disclosed
WO-2023081923-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Frequency Therapeutics, Inc. (US) 2023-05-11 WO disclosed
CN-116003309-A Hydrazide compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2023-04-25 CN disclosed
EP-4161916-A1 SUBSTITUTED ISOQUINOLINYLMETHYL AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-04-12 EP disclosed
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 EP disclosed
CN-115667225-A Compound (I) 詹森药业有限公司 2023-01-31 CN disclosed
CN-115551864-A Substituted tricyclic amides, analogs thereof, and methods of using the same 爱彼特生物制药公司 2022-12-30 CN disclosed
EP-4077308-A1 ANTI-MALARIAL AGENTS The Board of Regents of the University of Texas System (US) 2022-10-26 EP disclosed
CN-114846004-A Novel antimalarial drug 德克萨斯大学系统董事会 2022-08-02 CN disclosed
CN-114450281-A Inhibitor compounds 辛塞拉治疗私人有限公司 2022-05-06 CN disclosed